ELAN vs. INSM: Elanco Animal Health vs. Insmed Stock Comparison

Company Profile

Elanco Animal Health (ELAN) and Insmed (INSM) both fall under the Pharmaceuticals, Biotechnology & Life Sciences industry group, but ELAN is classified in Pharmaceuticals while INSM is classified in Biotechnology.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Elanco Animal Health (ELAN) has no ROE value reported for this period; Insmed (INSM) reports a negative figure of -72.45%, which needs context because negative ROE can reflect losses or negative shareholders’ equity.

Both Elanco Animal Health (ELAN) at -2.86% and Insmed (INSM) at -39.85% report negative net margin values, usually indicating net losses over the period.

Insmed (INSM) reports a negative operating margin of -15.60%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile Elanco Animal Health (ELAN) reports 6.64%, ranking against industry peers normally.

Profitability Metrics

Growth

Insmed (INSM) at 66.73% sits in the top revenue growth quartile, while Elanco Animal Health (ELAN) at 6.22% is closer to the peer norm — faster top-line expansion for INSM.

Only one side can be read here: Elanco Animal Health (ELAN) reports EPS growth of -169.12%, ranked against its industry; Insmed (INSM) has no EPS growth figure this period.

Growth Metrics

Financial Strength

Short-term liquidity can only be read on one side of this pairing: Insmed (INSM) shows current ratio of 2.86 against its industry benchmark, while Elanco Animal Health (ELAN) has no reading this period.

Elanco Animal Health (ELAN) at 0.64 carries an industry-typical debt-to-equity mix, while Insmed (INSM) at 1.01 uses more debt funding than most peers.

Financial Strength Metrics

Dividends

Neither Elanco Animal Health (ELAN) nor Insmed (INSM) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Neither Elanco Animal Health (ELAN) nor Insmed (INSM) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Dividend Metrics

Valuation

Neither Elanco Animal Health (ELAN) nor Insmed (INSM) reports a P/E ratio value for this period, so a direct comparison isn’t possible.

Elanco Animal Health (ELAN) at 2.50 sits in the cheaper P/S ratio quartile while Insmed (INSM) at 16.52 prices around its industry’s middle — ELAN costs less per dollar of sales, though read it alongside growth and margins.

Elanco Animal Health (ELAN) at 1.95 sits near its industry’s typical P/B ratio, while Insmed (INSM) at 34.55 prices above its benchmark range — INSM looks rich relative to book.

Valuation Metrics